Bring your drug candidate from concept to commercial with one dedicated bioanalysis partner. Get our team of QC Scientists’ in-depth understanding of the physicochemical properties of the individual and combined elements of ADCs. You can be confident that the appropriate analytical and bioanalytical methods are selected to monitor the functional attributes of the resulting drug substance.

Proven analytical capabilities for ADC manufacturing

You’ll get access to a global network of development and manufacturing sites in North America, Europe and Asia; equipped with industry-leading expertise.

Dedicated team to support new method development, method transfers and qualification/validation that offers:

  • Cleaning (swab/rinse by TOC; conductivity)
  • Complete analytical development packages
  • DS/DP release testing and stability testing
  • In-process testing (24/7), PAT
  • Environmental monitoring
  • Raw material testing

Complete access to a broad range of analytical techniques:

For your ADC drug substance and drug product release and stability testing stages, you’ll have access to our team, bringing you a range of analytical approaches, including:

  • Dot Blot/ ELISA
  • CE (e.g. CE-SDS)
  • Color, appearance, turbidity
  • pH, osmolality, conductivity
  • icIEF (charge heterogeneity)
  • UV (e.g. for protein concentration)
  • HPLC (e.g. SEC, HIC, RP) and UPLC
  • Particle testing (visible and subvisible)
  • Cell-based potency assays, incl. preparation of cell banks
  • Microbiology group: endotoxin, bioburden, identification of microorganisms
Our global network of development and manufacturing sites in North America, Europe and Asia are equipped with industry leading expertise and will enable you to bring your drug candidate from concept to commercial with one dedicated partner.